MedTrace Logo

Treatment of Misophonia: Comparison of Exposure and Sound Therapy

NCT05993286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2023-08-15

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effects of possible treatments in misophonics. The main question it aims to answer is:

\- Is exposure more effective on misophonic symptoms than sound therapy? Participants are randomly assinged to three groups of treatment;

1. Psychoeducation
2. Psychoeducation + Exposure
3. Psychoeducation + Sound Therapy

Conditions

  • Misophonia

Interventions

BEHAVIORAL

Exposure Therapy

At Week 0, the homework was to expose oneself to these sounds for 20 minutes a day, three days a week for three weeks. At the Week 3 interview, the frequency and severity of the homework were adjusted based on the degree of improvement in the symptoms and the person's adherence to the instructions.

OTHER

Sound Therapy

Participants were asked to listen to specifically modulated music for twenty minutes a day, three days a week, for the first three weeks. At the Week 3 assessment, if the patient reported no or little benefit in their misophonia symptoms, the instruction was modified (intensified) to listening to the same music for forty minutes a day, three days a week.

OTHER

Psychoeducation

A psychoeducation session, prepared by the research team was delivered by the investigator to each patient at the study intake.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Cengiz Kılıç, Prof. · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2021-04-01
Completion
2021-04-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05993286 on ClinicalTrials.gov